Share：
Share this content in WeChat
X
[Chinese][PDF]4483
• Clinical Articles •
Study on the application value of DWI combined with conventional MRI in making surgical plan of PDS for advanced ovarian cancer
YANG Qingling  REN Jing  HAN Ye  WANG Yang  XIAO Zunjian  GUO Yan  SHEN Fan 

Cite this article as: YANG Q L, REN J, HAN Y, et al. Study on the application value of DWI combined with conventional MRI in making surgical plan of PDS for advanced ovarian cancer[J]. Chin J Magn Reson Imaging, 2023, 14(7): 73-77, 92. DOI:10.12015/issn.1674-8034.2023.07.013.


[Abstract] Objective To investigate the clinical application value of diffusion weighted imaging (DWI) combined with conventional MRI in making surgical plan of primary debulking surgery (PDS) in patients with advanced ovarian cancer.Materials and Methods The imaging data of 57 patients with advanced ovarian cancer confirmed by pathology in our hospital from November 2018 to June 2022 were retrospectively analyzed. All patients underwent abdominal conventional MRI, DWI and enhanced computed tomography (CT), and then PDS surgery was performed. According to the FAGOTTI laparoscopic score and peritoneal cancer index (PCI) and combined with multiple disciplinary team discussion in our hospital, the anatomical areas to be observed in the imaging data of this study were determined. The presence of metastasis in each area was recorded and need for the assistance of corresponding departments was determined. Using intraoperative records and pathology as the gold standard, the diagnostic efficacy of DWI combined with conventional MRI and enhanced CT was compared. χ2 test was used to compare the statistical differences between the two groups, and to compare the formulation value of the two methods of imaging examinations in the PDS surgery plan for advanced ovarian cancer. Kappa analysis evaluated the consistency of two radiologists in determining clinical assistance departments.Results In this group of 57 patients, the cases with different surgical plans were recorded as follows: 9 cases of gynecologic surgery alone, 7 cases required the assistance of hepatobiliary surgery department, 5 cases required the assistance of digestive surgery department, 23 cases required the assistance of both liver and gallbladder surgery and digestive surgery department, 5 cases required the assistance of both digestion and urology surgery department, 1 case required the assistance with hepatobiliary surgery and urology department, liver and gallbladder surgery, digestive surgery and urology common assist with surgery in 7 cases. The coincidence of preoperative DWI combined with MRI (38/57) was significantly higher than that of enhanced CT (16/57) (P＜0.001). Intraoperative records showed that 40, 38 and 13 cases needed assistance from digestive surgery, hepatobiliary surgery and urology surgery, respectively. Preoperative DWI combined with MRI plain scan confirmed that 30, 36 and 10 cases needed assistance from above departments, with accuracy of 80.70%, 91.23% and 87.72%, respectively. Preoperative enhanced CT showed 18, 24 and 5 cases from above departments, with the accuracy of 57.89%, 64.91% and 78.95%, respectively. The accuracy of DWI combined with conventional MRI was higher than that of contrast-enhanced CT (χ2=4.762, P=0.027; χ2=4.050, P=0.041) in patients requiring digestive surgery and hepatobiliary surgery. The consistency range of clinical assistance departments determined by two radiologists under different imaging methods was 0.437-0.843, both of which were above medium.Conclusions Compared with enhanced CT, DWI combined with conventional MRI has higher accuracy and better clinical significance in making surgical plan of PDS for advanced ovarian cancer.
[Keywords] ovarian cancer；primary debulking surgery；magnetic resonance imaging；computed tomography

YANG Qingling   REN Jing*   HAN Ye   WANG Yang   XIAO Zunjian   GUO Yan   SHEN Fan  

Department of Radiology, Xijing Hospital, Air Force Medical University, Xi'an 710032, China

Corresponding author: Ren J, E-mail: jrenmm@126.com

Conflicts of interest   None.

ACKNOWLEDGMENTS Natural Science Basic Research Program of Shaanxi Province (No. 2021JZ-25); Science and Technology Innovation Team of Shaanxi Province (No. 2021TD-39).
Received  2023-02-13
Accepted  2023-06-28
DOI: 10.12015/issn.1674-8034.2023.07.013
Cite this article as: YANG Q L, REN J, HAN Y, et al. Study on the application value of DWI combined with conventional MRI in making surgical plan of PDS for advanced ovarian cancer[J]. Chin J Magn Reson Imaging, 2023, 14(7): 73-77, 92. DOI:10.12015/issn.1674-8034.2023.07.013.

[1]
HUANG H T, CHEN S Y, GENG X, et al. Ovarian cancer in China: trends in incidence and mortality, 2005—2016[J]. Chin Gen Pract, 2022, 25(8): 990-994. DOI: 10.12114/j.issn.1007-9572.2021.01.606.
[2]
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30. DOI: 10.3322/caac.21590.
[3]
LU H W, WU B, XU M C, et al. Interpretation of 2022 NCCN clinical practice guidelines to ovarian cancer including carcinoma of fallopian tube and primary peritoneal carcinoma(1^(st) edition)[J]. Chin J Pract Gynecol Obstet, 2022, 38(3): 310-318. DOI: 10.19538/j.fk2022030113.
[4]
QUERLEU D, PLANCHAMP F, CHIVA L, et al. European society of gynaecological oncology (ESGO) guidelines for ovarian cancer surgery[J]. Int J Gynecol Cancer, 2017, 27(7): 1534-1542. DOI: 10.1097/IGC.0000000000001041.
[5]
HUANG S M, WU S Y, SUN Y F, et al. Meta-analysis of the diagnostic value of different imaging methods for peritoneal metastasis of ovarian cancer[J]. Chin J Interv Radiol Electron Ed, 2021, 9(2): 177-182. DOI: 10.3877/cma.j.issn.2095-5782.2021.02.011.
[6]
WIMBERGER P, LEHMANN N, KIMMIG R, et al. Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase Ⅲ study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)[J]. Gynecol Oncol, 2007, 106(1): 69-74. DOI: 10.1016/j.ygyno.2007.02.026.
[7]
ZHOU Q, LONG X T. Application and prospect of multidisciplinary team in gynecological malignant tumor in China[J]. China Ind Econ, 2020, 36(1): 32-35. DOI: 10.19538/j.fk2020010108.
[8]
FORSTNER R, SALA E, KINKEL K, et al. ESUR guidelines: ovarian cancer staging and follow-up[J]. Eur Radiol, 2010, 20(12): 2773-2780. DOI: 10.1007/s00330-010-1886-4.
[9]
ESQUIVEL J, CHUA T C, STOJADINOVIC A, et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study[J]. J Surg Oncol, 2010, 102(6): 565-570. DOI: 10.1002/jso.21601.
[10]
VAN 'T SANT I, VAN EDEN W J, ENGBERSEN M P, et al. Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery[J]. Br J Surg, 2019, 106(4): 491-498. DOI: 10.1002/bjs.10989.
[11]
DONG L, LI K, PENG T S. Diagnostic value of diffusion-weighted imaging/magnetic resonance imaging for peritoneal metastasis from malignant tumor: a systematic review and meta-analysis[J/OL]. Medicine, 2021, 100(5): e24251 [2022-12-20]. https://pubmed.ncbi.nlm.nih.gov/33592867/. DOI: 10.1097/MD.0000000000024251.
[12]
FAGOTTI A, FANFANI F, LUDOVISI M, et al. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study[J]. Gynecol Oncol, 2005, 96(3): 729-735. DOI: 10.1016/j.ygyno.2004.11.031.
[13]
FAGOTTI A, FERRANDINA G, FANFANI F, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study[J]. Ann Surg Oncol, 2006, 13(8): 1156-1161. DOI: 10.1245/ASO.2006.08.021.
[14]
JACQUET P, SUGARBAKER P H. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis[J]. Cancer Treat Res, 1996, 82: 359-374. DOI: 10.1007/978-1-4613-1247-5_23.
[15]
SAHDEV A. CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning[J/OL]. Cancer Imaging, 2016, 16(1): 19 [2022-12-21]. https://pubmed.ncbi.nlm.nih.gov/27484100/. DOI: 10.1186/s40644-016-0076-2.
[16]
VAN 'T SANT I, ENGBERSEN M P, BHAIROSING P A, et al. Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis[J]. Eur Radiol, 2020, 30(6): 3101-3112. DOI: 10.1007/s00330-019-06524-x.
[17]
BOZKURT M, DOGANAY S, KANTARCI M, et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values[J]. Eur J Radiol, 2011, 80(2): 224-228. DOI: 10.1016/j.ejrad.2010.06.004.
[18]
WANG Q Z, DONG H, ZHOU P. Application value of combined detection of DCE-MRI and serum tumor markers HE4, Ki67, and HK10 in the diagnosis of ovarian cancer[J/OL]. Contrast Media Mol Imaging, 2022, 2022: 1533261 [2022-12-21]. http://pubmed.ncbi.nlm.nih.gov/35815060. DOI: 10.1155/2022/1533261.
[19]
SONG X L, REN J L, ZHAO D, et al. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms[J]. Eur Radiol, 2021, 31(1): 368-378. DOI: 10.1007/s00330-020-07112-0.
[20]
WEI M X, BO F, CAO H, et al. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis[J]. Acta Radiol, 2021, 62(7): 966-978. DOI: 10.1177/0284185120944916.
[21]
BLOMQVIST L, NORDBERG G F, NURCHI V M, et al. Gadolinium in medical imaging-usefulness, toxic reactions and possible countermeasures-a review[J/OL]. Biomolecules, 2022, 12(6): 742 [2022-12-21]. https://pubmed.ncbi.nlm.nih.gov/35740867/. DOI: 10.3390/biom12060742.
[22]
LOW R N, GURNEY J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI[J]. J Magn Reson Imaging, 2007, 25(4): 848-858. DOI: 10.1002/jmri.20864.
[23]
MICHIELSEN K, VERGOTE I, OP DE BEECK K, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT[J]. Eur Radiol, 2014, 24(4): 889-901. DOI: 10.1007/s00330-013-3083-8.
[24]
RIZZO S, DE PIANO F, BUSCARINO V, et al. Pre-operative evaluation of epithelial ovarian cancer patients: role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study[J/OL]. Eur J Radiol, 2020, 123: 108786 [2022-12-21]. https://pubmed.ncbi.nlm.nih.gov/31862634. DOI: 10.1016/j.ejrad.2019.108786.
[25]
MICHIELSEN K, DRESEN R, VANSLEMBROUCK R, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer[J]. Eur J Cancer, 2017, 83: 88-98. DOI: 10.1016/j.ejca.2017.06.010.
[26]
ESPADA M, GARCIA-FLORES J R, JIMENEZ M, et al. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma[J]. Eur Radiol, 2013, 23(9): 2636-2642. DOI: 10.1007/s00330-013-2837-7.
[27]
LEE E Y P, AN H, TSE K Y, et al. Molecular imaging of peritoneal carcinomatosis in ovarian carcinoma[J]. AJR Am J Roentgenol, 2020, 215(2): 305-312. DOI: 10.2214/AJR.19.22621.
[28]
PANEBIANCO V, DE BERARDINIS E, BARCHETTI G, et al. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer[J]. Eur Radiol, 2017, 27(9): 3759-3766. DOI: 10.1007/s00330-017-4758-3.
[29]
PANEBIANCO V, NARUMI Y, ALTUN E, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (vesical imaging-reporting and data system)[J]. Eur Urol, 2018, 74(3): 294-306. DOI: 10.1016/j.eururo.2018.04.029.
[30]
SHALABY E A, MOHAMED A R, ELKAMMASH T H, et al. Role of multiparametric magnetic resonance imaging in the diagnosis and staging of urinary bladder cancer[J]. Curr Urol, 2022, 16(3): 127-135. DOI: 10.1097/CU9.0000000000000128.
[31]
DE PERROT T, SADJO ZOUA C, GLESSGEN C G, et al. Diffusion-weighted MRI in the genitourinary system[J/OL]. J Clin Med, 2022, 11(7): 1921 [2022-12-21]. https://pubmed.ncbi.nlm.nih.gov/35407528/. DOI: 10.3390/jcm11071921.
[32]
LI Q, CAO B H, TAN Q X, et al. Prediction of muscle invasion of bladder cancer: a comparison between DKI and conventional DWI[J/OL]. Eur J Radiol, 2021, 136: 109522 [2022-09-18]. https://pubmed.ncbi.nlm.nih.gov/33434860/. DOI: 10.1016/j.ejrad.2021.109522.
[33]
PIZZI A D, MASTRODICASA D, MARCHIONI M, et al. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach[J]. Eur Radiol, 2021, 31(6): 3874-3883. DOI: 10.1007/s00330-020-07473-6.

PREV The value of radiomics based on MRI T2WI in predicting the post-acute pancreatitis diabetes mellitus
NEXT The value of the apparent diffusion coefficient in preoperative prediction of myometrial infiltration, Ki-67 and P53 expression levels in endometrial carcinoma
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn